Semigran Marc - Aug 17, 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Development Officer
Signature
/s/ John R. Moore, Attorney-in-Fact for Semigran Marc
Stock symbol
EWTX
Transactions as of
Aug 17, 2023
Transactions value $
$0
Form type
4
Date filed
8/18/2023, 07:13 PM
Previous filing
Jan 3, 2023
Next filing
Aug 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +133K $0.00 133K Aug 17, 2023 Common Stock 133K $7.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date.